News
Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...
AstraZeneca (AZN) stock in focus as its antibody drug Imfinzi gains EU panel support for treating muscle-invasive bladder ...
The two active substances are antivirals that inhibit HIV reverse transcriptase through incorporation into the viral DNA, ...
After Verizon agreed to end its diversity, equity and inclusion policies, the FCC — led by Trump-appointed chairman Brendan Carr — approved the ... announcement, the agency said, Verizon ...
1 inhibitor approved for both perioperative and neoadjuvant-only treatment of resectable non-small cell lung cancer in the European Union ...
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
LONDON, May 14 (Reuters) - European governments are examining whether U.S. President Donald Trump can force them to pay more for prescription medicines, after he issued an executive order to lower ...
today announced that the European Medicines Agency (EMA) has approved its Clinical Trial Application (CTA) to conduct its pivotal Phase 2B/3, multi-center, randomized, double-blind, placebo ...
Biodexa Pharmaceuticals PLC (“Biodexa” or the“Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet ...
A Royal charter amendment enabling legal executives to call themselves ’CILEX chartered paralegals’ has received approval from the Privy Council, the Chartered Institute of Legal Executives ...
In 2022, the regulator the Medicines and Healthcare products Regulatory Agency (MHRA) and the Committees of Advertising Practice (CAP) issued a joint enforcement notice about the advertising of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results